keyword
MENU ▼
Read by QxMD icon Read
search

Augmentation adhd

keyword
https://www.readbyqxmd.com/read/29360046/knowledge-of-performance-feedback-among-boys-with-adhd
#1
Jason C Bishop, Luke E Kelly, Michael Hull
BACKGROUND: Children with attention deficit-hyperactivity disorder (ADHD) often experience delays in acquiring competence completing fundamental motor skills. The effects of augmented prescriptive knowledge of performance feedback (PKP) have not been explored as a possible component solution. AIMS: The purpose of this study was to test the motor learning effects of KP among boys with ADHD. METHODS AND PROCEDURES: Thirty-one boys with ADHD, randomly selected into either a treatment or a control group, completed a series of cornhole games...
January 19, 2018: Research in Developmental Disabilities
https://www.readbyqxmd.com/read/29246205/the-autism-tics-adhd-and-other-comorbidities-inventory-a-tac-previous-and-predictive-validity
#2
Caroline Mårland, Paul Lichtenstein, Alessio Degl'Innocenti, Tomas Larson, Maria Råstam, Henrik Anckarsäter, Christopher Gillberg, Thomas Nilsson, Sebastian Lundström
BACKGROUND: Reliable and easy to administer screening instruments focusing on neurodevelopmental disorders and associated conditions are scarce. The Autism-Tics, AD/HD and other Comorbidities inventory (A-TAC) has previously been validated and reporting good- excellent validity for several disorders. This article aims to expand these findings by including more conditions in a substantially larger sample augmented with the Swedish National Patient Register (NPR). METHODS: Since 2004 parents of all 9-year-old Swedish twins have been invited to participate in a telephone interview in the Child and Adolescent Twin Study in Sweden, CATSS...
December 16, 2017: BMC Psychiatry
https://www.readbyqxmd.com/read/28978497/attention-deficit-hyperactivity-disorder-is-there-an-app-for-that-suitability-assessment-of-apps-for-children-and-young-people-with-adhd
#3
Lauren Powell, Jack Parker, Naomi Robertson, Valerie Harpin
BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is a complex highly comorbid disorder, which can have a huge impact on those with ADHD, their family, and the community around them. ADHD is currently managed using pharmacological and nonpharmacological interventions. However, with advances in technology and an increase in the use of mobile apps, managing ADHD can be augmented using apps specifically designed for this population. However, little is known regarding the suitability and usability of currently available apps...
October 4, 2017: JMIR MHealth and UHealth
https://www.readbyqxmd.com/read/28875352/specificity-of-reward-sensitivity-and-parasympathetic-based-regulation-among-children-with-attention-deficit-hyperactivity-and-disruptive-behavior-disorders
#4
Rachel B Tenenbaum, Erica D Musser, Joseph S Raiker, Erika K Coles, Elizabeth M Gnagy, William E Pelham
Attention-deficit/hyperactivity disorder (ADHD) is associated with disruptionsin reward sensitivity and regulatory processes. However, it is unclear whether thesedisruptions are better explained by comorbid disruptive behavior disorder (DBD)symptomology. This study sought to examine this question using multiple levels ofanalysis (i.e., behavior, autonomic reactivity). One hundred seventeen children (aged 6 to 12 years; 72.6% male; 69 with ADHD) completed theBalloon-Analogue Risk Task (BART) to assess external reward sensitivity behaviorally...
September 6, 2017: Journal of Abnormal Child Psychology
https://www.readbyqxmd.com/read/28455812/treatment-patterns-among-children-and-adolescents-with-attention-deficit-hyperactivity-disorder-with-or-without-psychiatric-or-neurologic-comorbidities-in-sweden-a-retrospective-cohort-study
#5
Vanja Sikirica, Per A Gustafsson, Charles Makin
INTRODUCTION: Attention-deficit/hyperactivity disorder (ADHD) is a common psychiatric disorder in children/adolescents and occurs frequently with psychiatric/neurologic comorbidities. The objective of this study was to assess the impact of psychiatric/neurologic comorbidities on pharmacotherapy patterns among patients with ADHD in Sweden. METHODS: A retrospective cohort analysis was conducted using medical records from a regional database in Sweden. Patients aged 6-17 years, with ≥1 prescription for ADHD medication between July 1, 2007 and June 30, 2009, and continuously active in the database for ≥12 months before and after their prescription index date were selected...
June 2017: Neurology and Therapy
https://www.readbyqxmd.com/read/28277151/sequenced-neurocognitive-and-behavioral-parent-training-for-the-treatment-of-adhd-in-school-age-children
#6
A Chacko, A-C V Bedard, D Marks, G Gopalan, N Feirsen, J Uderman, A Chimiklis, E Heber, M Cornwell, L Anderson, A Zwilling, M Ramon
The present study examines the potential of sequencing a neurocognitive intervention with behavioral parent training (BPT) to improve executive functions (EFs), psychiatric symptoms, and multiple indices of functional impairment in school-age children aged 7 to 11 years who have been diagnosed with attention-deficit/hyperactivity disorder (ADHD). Specifically, in a randomized controlled trial design, 85 children were assigned to either Cogmed Working Memory Training (CWMT) followed by an empirically supported, manualized BPT intervention, or to a placebo version of CWMT followed by the same BPT intervention...
February 23, 2017: Child Neuropsychology: a Journal on Normal and Abnormal Development in Childhood and Adolescence
https://www.readbyqxmd.com/read/28212067/the-treatment-of-severe-childhood-aggression-study-12-weeks-of-extended-blinded-treatment-in-clinical-responders
#7
Robert L Findling, Lisa Townsend, Nicole V Brown, L Eugene Arnold, Kenneth D Gadow, David J Kolko, Nora K McNamara, Devin S Gary, Dana B Kaplin, Cristan A Farmer, Heidi Kipp, Craig Williams, Eric M Butter, Oscar G Bukstein, Robert Rice, Kristin Buchan-Page, Brooke S G Molina, Michael G Aman
OBJECTIVES: Previous "Treatment of Severe Childhood Aggression" (TOSCA) reports demonstrated that many children with severe physical aggression and attention-deficit/hyperactivity disorder (ADHD) responded well to two randomized treatments (parent training [PT]+stimulant+placebo = Basic vs. PT+stimulant+risperidone = Augmented) for 9 weeks. An important clinical question is whether these favorable outcomes are maintained over longer times. METHODS: Clinical responders to the 9-week trial (n = 103/168), defined as Clinical Global Impressions (CGI)-Improvement of much/very much improved plus substantial reduction in parent ratings of disruptiveness, were followed another 12 weeks (21 weeks total) while remaining on blinded treatment...
February 2017: Journal of Child and Adolescent Psychopharmacology
https://www.readbyqxmd.com/read/28118752/the-impact-of-adjunctive-guanfacine-extended-release-on-stimulant-adherence-in-children-adolescents-with-attention-deficit-hyperactivity-disorder
#8
Juliana Meyers, Kavita Gajria, Sean D Candrilli, Moshe Fridman, Vanja Sikirica
AIM: To assess stimulant adherence among children/adolescents with attention-deficit/hyperactivity disorder (ADHD) augmenting stimulants with guanfacine extended-release (GXR). PATIENTS & METHODS: Inclusion criteria: 6-17 years, ≥1 ADHD diagnosis, ≥1 long-acting and/or short-acting stimulant with GXR augmentation. Modified medication possession ratio (mMPR; days medication available/days in period, excluding medication holidays) was assessed; mMPR <0.80 nonadherent...
March 2017: Journal of Comparative Effectiveness Research
https://www.readbyqxmd.com/read/28065167/diagnostic-utility-of-brain-activity-flow-patterns-analysis-in-attention-deficit-hyperactivity-disorder
#9
J Biederman, P Hammerness, B Sadeh, Z Peremen, A Amit, H Or-Ly, Y Stern, A Reches, A Geva, S V Faraone
BACKGROUND: A previous small study suggested that Brain Network Activation (BNA), a novel ERP-based brain network analysis, may have diagnostic utility in attention deficit hyperactivity disorder (ADHD). In this study we examined the diagnostic capability of a new advanced version of the BNA methodology on a larger population of adults with and without ADHD. METHOD: Subjects were unmedicated right-handed 18- to 55-year-old adults of both sexes with and without a DSM-IV diagnosis of ADHD...
May 2017: Psychological Medicine
https://www.readbyqxmd.com/read/28033486/adhd-and-temporality-a-desynchronized-way-of-being-in-the-world
#10
Mikka Nielsen
ADHD is, I argue, an impairment in sense of time and a matter of difference in rhythm; it can be understood as a certain being in the world, or more specifically, as a disruption in the experience of time and a state of desynchronization and arrhythmia. Through excerpts of interviews with adults diagnosed with ADHD and observations, I illustrate how impairment in time is manifested in an embodied experience of being out of sync. I suggest that the experience of ADHD is characterized as 1) an inner restlessness and bodily arrhythmia; 2) an intersubjective desynchronization between the individual and its surroundings; and 3) a feeling of lagging behind socially due to difficulties in social skills...
December 29, 2016: Medical Anthropology
https://www.readbyqxmd.com/read/27746700/effects-of-maternal-symptom-ratings-and-other-clinical-features-on-short-term-treatment-response-to-oros-methylphenidate-in-children-and-adolescents-with-adhd-in-a-naturalistic-clinical-setting
#11
Esra Cop Tasgin, Ozgur Oner, Pinar Yurtbasi, Kerim Munir
OBJECTIVE: To investigate the effect of Attention Deficit Hyperactivity Disorder (ADHD), antisocial behavior and anxiety/depression ratings of mothers, and child and adolescents' age, gender, ADHD subtype, and comorbidity on one-month drug treatment response to OROS methylphenidate in ADHD in a naturalistic setting. METHODS: The analyses included 223 subjects (191 boys, 32 girls; age 6-15 years, mean: 9.4) treated with OROS methylphenidate (18-72 mg/day, mean: 31 mg/d; 0...
2016: Bulletin of Clinical Psychopharmacology [Klinik Psikofarmakoloji Bülteni]
https://www.readbyqxmd.com/read/27238065/severely-aggressive-children-receiving-stimulant-medication-versus-stimulant-and-risperidone-12-month-follow-up-of-the-tosca-trial
#12
MULTICENTER STUDY
Kenneth D Gadow, Nicole V Brown, L Eugene Arnold, Kristin A Buchan-Page, Oscar G Bukstein, Eric Butter, Cristan A Farmer, Robert L Findling, David J Kolko, Brooke S G Molina, Robert R Rice, Jayne Schneider, Michael G Aman
OBJECTIVE: The objective of this study was to evaluate 52-week clinical outcomes of children with co-occurring attention-deficit/hyperactivity disorder (ADHD), disruptive behavior disorder, and serious physical aggression who participated in a prospective, longitudinal study that began with a controlled, 9-week clinical trial comparing the relative efficacy of parent training + stimulant medication + placebo (Basic; n = 84) versus parent training + stimulant + risperidone (Augmented; n = 84)...
June 2016: Journal of the American Academy of Child and Adolescent Psychiatry
https://www.readbyqxmd.com/read/27186140/single-exposure-of-dopamine-d1-antagonist-prevents-and-d2-antagonist-attenuates-methylphenidate-effect
#13
Catherine M Claussen, Lindsey J Witte, Nachum Dafny
Methylphenidate (MPD) is a readily prescribed drug for the treatment of attention deficit hyperactivity disorder (ADHD) and moreover is used illicitly by youths for its cognitive-enhancing effects and recreation. MPD exposure in rodents elicits increased locomotor activity. Repetitive MPD exposure leads to further augmentation of their locomotor activity. This behavioral response is referred to as behavioral sensitization. Behavioral sensitization is used as an experimental marker for a drug's ability to elicit dependence...
2015: Journal of Experimental Pharmacology
https://www.readbyqxmd.com/read/27117555/the-children-s-attention-deficit-hyperactivity-disorder-telemental-health-treatment-study-caregiver-outcomes
#14
RANDOMIZED CONTROLLED TRIAL
Ann Vander Stoep, Carolyn A McCarty, Chuan Zhou, Carol M Rockhill, Erin N Schoenfelder, Kathleen Myers
The Children's Attention-deficit Hyperactivity Disorder (ADHD) Telemental Health Treatment Study (CATTS) tested the hypotheses that children and caregivers who received guideline-based treatment delivered through a hybrid telehealth service delivery model would experience greater improvements in outcomes than children and caregivers receiving treatment via a comparison delivery model. Here, we present caregiver outcomes. 88 primary care providers (PCPs) in seven geographically underserved communities referred 223 children (ages 5...
January 2017: Journal of Abnormal Child Psychology
https://www.readbyqxmd.com/read/27087081/attenuation-of-methylphenidate-induced-sensitization-by-co-administration-of-buspirone
#15
Nausheen Alam, Rahila Najam, Sadaf Naeem
Methylphenidate, which inhibit dopamine transporter is effective in the treatment of ADHD (attention deficit hyperactivity disorder), but long term use of this drug is often associated with addiction and dependence. Locomotor sensitization development to psychostimulants like methylphenidate is an important contributor to drug abuse induced by psychostimulants. Different studies have shown that long term administration of drugs of abuse increases the effectiveness of 5-hydroxytryptamine (5-HT)-1A somatodendritic receptors...
March 2016: Pakistan Journal of Pharmaceutical Sciences
https://www.readbyqxmd.com/read/27009498/developing-mhealth-remote-monitoring-technology-for-attention-deficit-hyperactivity-disorder-a-qualitative-study-eliciting-user-priorities-and-needs
#16
Lucy Simons, Althea Z Valentine, Caroline J Falconer, Madeleine Groom, David Daley, Michael P Craven, Zoe Young, Charlotte Hall, Chris Hollis
BACKGROUND: Guidelines in the United Kingdom recommend that medication titration for attention deficit hyperactivity disorder (ADHD) should be completed within 4-6 weeks and include regular reviews. However, most clinicians think that weekly clinic contact is infeasible, and audits have shown that this timeline is rarely achieved. Thus, a more effective monitoring and review system is needed; remote monitoring technology (RMT) may be one way to improve current practice. However, little is known about whether patients with ADHD, their families, and clinicians would be interested in using RMT...
2016: JMIR MHealth and UHealth
https://www.readbyqxmd.com/read/27007844/thalamic-reticular-impairment-underlies-attention-deficit-in-ptchd1-y-mice
#17
Michael F Wells, Ralf D Wimmer, L Ian Schmitt, Guoping Feng, Michael M Halassa
Developmental disabilities, including attention-deficit hyperactivity disorder (ADHD), intellectual disability (ID), and autism spectrum disorders (ASD), affect one in six children in the USA. Recently, gene mutations in patched domain containing 1 (PTCHD1) have been found in ~1% of patients with ID and ASD. Individuals with PTCHD1 deletion show symptoms of ADHD, sleep disruption, hypotonia, aggression, ASD, and ID. Although PTCHD1 is probably critical for normal development, the connection between its deletion and the ensuing behavioural defects is poorly understood...
April 7, 2016: Nature
https://www.readbyqxmd.com/read/26740931/does-mindfulness-meditation-improve-attention-in-attention-deficit-hyperactivity-disorder
#18
REVIEW
Vania Modesto-Lowe, Pantea Farahmand, Margaret Chaplin, Lauren Sarro
Attention deficit hyperactivity disorder (ADHD) manifests by high levels of inattention, impulsiveness and hyperactivity. ADHD starts in childhood and results in impairments that continue into adulthood. While hyperactivity declines over time, inattention and executive function difficulties persist, leading to functional deficits. Adolescents and adults with ADHD have pervasive impairment in interpersonal and family relationships. They may develop addiction, delinquent behavior and comorbid psychiatric disorders...
December 22, 2015: World Journal of Psychiatry
https://www.readbyqxmd.com/read/26598594/atomoxetine-augmentation-in-a-case-of-treatment-resistant-panic-disorder-with-multiple-augments-failure-a-case-report
#19
Dushad Ram, Shwetha Patil, Basavana Gowdappa, Iyshwarya Rajalakshmi
Atomoxetine, a selective norepinephrine inhibitor, is effective in comorbid anxiety and attention deficit hyperactivity disorder, however its role in panic disorder is unknown. We are presenting a case of panic disorder, who initially partially responded to clonazepam. When clonazepam was added with sertraline, escitalopram, desvenlafaxin, she did not improve significantly until paroxetine was added. When clonazepam-paroxetine combination was added with propranolol, etizolam, olanzepine, risperidone and amisulpride the symptom remission did not occur until a trial of Atomoxetine was done...
December 31, 2015: Clinical Psychopharmacology and Neuroscience: the Official Scientific Journal of the Korean College of Neuropsychopharmacology
https://www.readbyqxmd.com/read/26529542/interaction-between-methylphenidate-methadone-and-different-antidepressant-drugs-on-antinociception-in-mice-and-possible-clinical-implications
#20
Shaul Schreiber, Miaad Bader, Vardit Rubovitch, Chaim G Pick
OBJECTIVES: Methylphenidate (MPH), a psychostimulant used for treatment of attention deficit hyperactivity disorder (ADHD), is widely used by patients on antidepressants and methadone maintenance treatment (MMT). Preclinical studies showed MPH to exert analgesic effects when given alone or with morphine. METHODS: Using the hotplate assay on mice, we studied the interaction of acute doses of MPH with sub-threshold doses of methadone and different antidepressant medications and the interaction of increasing doses of MPH with chronic methadone...
November 3, 2015: World Journal of Biological Psychiatry
keyword
keyword
120068
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"